These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 16009400

  • 21. Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome.
    Oral B, Mermi B, Dilek M, Alanoğlu G, Sütçü R.
    Gynecol Endocrinol; 2009 Feb; 25(2):110-6. PubMed ID: 19253106
    [Abstract] [Full Text] [Related]

  • 22. Dyslipidemias and fibrinolysis.
    Puccetti L, Bruni F, Pasqui AL, Pastorelli M, Bova G, Cercignani M, Palazzuoli A, Auteri A.
    Ital Heart J; 2002 Oct; 3(10):579-86. PubMed ID: 12478815
    [Abstract] [Full Text] [Related]

  • 23. Vascular endothelial growth factor in severe sepsis and septic shock.
    Karlsson S, Pettilä V, Tenhunen J, Lund V, Hovilehto S, Ruokonen E, Finnsepsis Study Group.
    Anesth Analg; 2008 Jun; 106(6):1820-6. PubMed ID: 18499616
    [Abstract] [Full Text] [Related]

  • 24. Plasminogen activator inhibitor 1: a new prognostic marker in septic shock.
    Pralong G, Calandra T, Glauser MP, Schellekens J, Verhoef J, Bachmann F, Kruithof EK.
    Thromb Haemost; 1989 Jun 30; 61(3):459-62. PubMed ID: 2678584
    [Abstract] [Full Text] [Related]

  • 25. Laboratory evidence of hyperfibrinolysis in association with low plasminogen activator inhibitor type 1 activity.
    Agren A, Wiman B, Schulman S.
    Blood Coagul Fibrinolysis; 2007 Oct 30; 18(7):657-60. PubMed ID: 17890953
    [Abstract] [Full Text] [Related]

  • 26. Gestational diabetes has no additional effect on plasma thrombin-activatable fibrinolysis inhibitor antigen levels beyond pregnancy.
    Akinci B, Demir T, Saygili S, Yener S, Alacacioglu I, Saygili F, Bayraktar F, Yesil S.
    Diabetes Res Clin Pract; 2008 Jul 30; 81(1):93-6. PubMed ID: 18406001
    [Abstract] [Full Text] [Related]

  • 27. [Fibrinolysis system in patients with sepsis in state of myelotoxic agranulocytosis].
    Galstian GM, Krechetova AV, Vasil'ev SA, Orel EB, Pustovoĭt LA, Egorova EO, Saridi EIu, Gemdzhian EG, Gorodetskiĭ VM.
    Anesteziol Reanimatol; 2012 Jul 30; (2):41-8. PubMed ID: 22834287
    [Abstract] [Full Text] [Related]

  • 28. The activation of neutrophil elastase-mediated fibrinolysis is not sufficient to overcome the fibrinolytic shutdown of disseminated intravascular coagulation associated with systemic inflammation.
    Gando S, Hayakawa M, Sawamura A, Hoshino H, Oshiro A, Kubota N, Jesmin S.
    Thromb Res; 2007 Jul 30; 121(1):67-73. PubMed ID: 17397908
    [Abstract] [Full Text] [Related]

  • 29. The vasopressin and copeptin response to infection, severe sepsis, and septic shock.
    Jochberger S, Dörler J, Luckner G, Mayr VD, Wenzel V, Ulmer H, Morgenthaler NG, Hasibeder WR, Dünser MW.
    Crit Care Med; 2009 Feb 30; 37(2):476-82. PubMed ID: 19114902
    [Abstract] [Full Text] [Related]

  • 30. Plasma Levels of Plasminogen Activator Inhibitor-1 (PAI-1) and Thrombin Activatable Fibrinolysis Inhibitor (TAFI) in Patients with Disseminated Intravascular Coagulation (DIC).
    Wada H, Nobori T, Watanabe R, Shiku H, Sakuragawa N.
    Turk J Haematol; 2002 Jun 05; 19(2):235-7. PubMed ID: 27264764
    [Abstract] [Full Text] [Related]

  • 31. Derangements of coagulation and fibrinolysis in critically ill patients with sepsis and septic shock.
    Vervloet MG, Thijs LG, Hack CE.
    Semin Thromb Hemost; 1998 Jun 05; 24(1):33-44. PubMed ID: 9515778
    [Abstract] [Full Text] [Related]

  • 32. [Early changes in function of hypothalamic-pituitary-target gland axis in patients with severe sepsis and septic shock].
    Cui N, Liu DW, Wang H, Zeng ZP, Long Y, Chai WZ, Liu HZ, Wang XT.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jun 05; 19(6):332-5. PubMed ID: 17577436
    [Abstract] [Full Text] [Related]

  • 33. Activated cytotoxic T cells and NK cells in severe sepsis and septic shock and their role in multiple organ dysfunction.
    Zeerleder S, Hack CE, Caliezi C, van Mierlo G, Eerenberg-Belmer A, Wolbink A, Wuillenmin WA.
    Clin Immunol; 2005 Aug 05; 116(2):158-65. PubMed ID: 15993363
    [Abstract] [Full Text] [Related]

  • 34. Serum IL-6 and IL-1-ra with sequential organ failure assessment scores in septic patients receiving high-volume haemofiltration and continuous venovenous haemofiltration.
    Ghani RA, Zainudin S, Ctkong N, Rahman AF, Wafa SR, Mohamad M, Manaf MR, Ismail R.
    Nephrology (Carlton); 2006 Oct 05; 11(5):386-93. PubMed ID: 17014550
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Hemoperfusion with a polymyxin B fiber column decreases clotting activity.
    Kushi H, Miki T, Sakagami Y, Sato J, Saito T, Tanjoh K.
    Ther Apher Dial; 2009 Dec 05; 13(6):528-33. PubMed ID: 19954477
    [Abstract] [Full Text] [Related]

  • 39. Active PAI-1 as marker for venous thromboembolism: case-control study using a comprehensive panel of PAI-1 and TAFI assays.
    Bollen L, Peetermans M, Peeters M, Van Steen K, Hoylaerts MF, Declerck PJ, Verhamme P, Gils A.
    Thromb Res; 2014 Nov 05; 134(5):1097-102. PubMed ID: 25193405
    [Abstract] [Full Text] [Related]

  • 40. Different mechanisms of fibrinolysis impairment among dyslipidemic subjects.
    Puccetti L, Pasqui AL, Pastorelli M, Bova G, Cercignani M, Palazzuoli A, Auteri A, Bruni F.
    Int J Clin Pharmacol Res; 2001 Nov 05; 21(3-4):147-55. PubMed ID: 12067144
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.